PKM2 is a direct target of miR-330-5p; therefore, CAF transfer of SNHG3 to breast cancer cells decreases miR-330-5p levels and increases PKM2 expression, inhibits mitochondrial OXPHOS, increases glycolysis carboxylation, and enhances breast tumor cell proliferation. This evidence concerns the gene PKM and breast cancer.